The Net Widens for Research on Rare Cancer
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Tag: Clinical trials
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...